Document is current
Any future updates will be listed below
-
Authors
Schreiber-Katz, Olivia
Siegler, Hannah Alexandra
Wieselmann, Gary
Kumpe, Mareike
Ranxha, Gresa
Petri, Susanne
Osmanovic, Alma https://orcid.org/0000-0002-6012-8423
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 24 August 2022
Accepted: 14 March 2023
First Online: 17 April 2023
Competing interests
: O.S.-K. has received honoraria as a speaker/consultant and/or funding for travel expenses from the German Neuromuscular Society “Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.), Novartis, Biogen GmbH, Biermann Verlag GmbH, and MK + S—Medizin, Kommunikation & Service GmbH. H.A.S. and G.W. report no conflicts of interest. M.K. and G.R. received travel cost compensations from Biogen GmbH. S.P. received honoraria as a speaker/consultant from Biogen GmbH, Roche, Novartis, Teva, Cytoki-netics Inc., and Desitin; and grants from DGM e.V, Federal Ministry of Education and Research, German Israeli Foundation for Scientific Research and Development, EU Joint Programme for Neurodegenerative Disease Research. A.O. received honoraria as a speaker/consultant from Biogen. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
